ProKidney’s Bold Move to Delay Dialysis | Winston–Salem News

ProKidney’s bold mission to delay dialysis is taking shape with its homegrown drug rilparencel, manufactured exclusively in Winston-Salem, offering patients potentially years more time. Despite a steep $111.7 million Q2 loss and $88 million operating deficit, the company has exploded from 30 to 800 employees in seven years, hiring aggressively across departments. With eyes on a $100M market and 100 trial sites by next year, FDA’s accelerated approval pathway could fast-track this life-changing therapy — even as investors watch closely. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ccfc27e4d576f564